For International Clinical Trials Day, Salah Hassan, talks about living with arthritis; explains why participating in the TAPER study is important to him and encourages others to be part of research.
The world’s first participant in a new COVID-19 trial taking place at MFT, is part of research that may provide important protection for people with a weakened immune system.
An interdisciplinary team led by Manchester scientists has adapted a technique to analyse data from stars to devise a way of accurately measuring the human body clock in hospital patients.
A new heart failure remote alert system for implanted heart devices developed by MFT researchers has proven to dramatically reduce the number of hospitalisations and improve patient care.
Patients at Manchester University NHS Foundation Trust (MFT) are benefitting from more than 40 combined years of healthcare experience provided by one family of nurses.
The next generation of health data scientists are taking their first steps into this rapidly expanding field, with internships at the UK’s largest NHS trust.
Research finds interrupting the treatment of vulnerable people on long-term immune supressing medicines for two weeks after a COVID-19 booster vaccination doubles antibody response.
Seven Manchester University NHS Foundation Trust (MFT) Consultants, are among 16 outstanding individuals announced by Manchester Academic Health Science Centre (MAHSC).